A Collection of Clinical and Epidemiologic Data Combined With Tissue and Blood From Patients With a Diagnosis of Neuroendocrine Tumors
Status: | Recruiting |
---|---|
Conditions: | Cancer, Cancer, Brain Cancer, Pancreatic Cancer |
Therapuetic Areas: | Oncology |
Healthy: | No |
Age Range: | 18 - Any |
Updated: | 8/5/2018 |
Start Date: | August 2008 |
End Date: | August 2020 |
Contact: | Diane Reidy-Lagunes, MD |
Phone: | 646-888-4185 |
Gastroenteropancreatic and Unknown Primary Neuroendocrine Registry A Collection of Clinical and Epidemiologic Data Combined With Tissue and Blood From Patients With a Diagnosis of Neuroendocrine Tumors
The purpose of this study is to establish a neuroendocrine tumor registry. A registry is a
collection of information. To create this registry, the investigators would like to get
information, blood and tumor samples from people with neuroendocrine tumors. By collecting
this information and material, the investigators are hoping to learn more about the genetic
causes of neuroendocrine tumors. All of this will help us to better understand neuroendocrine
cancer, so the investigators can find better ways to treat and diagnose this disease. DNA
will be taken from the blood samples and will be used in future studies. This will be an
important resource from which the investigators can study genes that may be related to a
higher risk of neuroendocrine tumors.
The information collected will include medical information, family history of cancer and your
answers to questions about how the cancer affects quality of life.
collection of information. To create this registry, the investigators would like to get
information, blood and tumor samples from people with neuroendocrine tumors. By collecting
this information and material, the investigators are hoping to learn more about the genetic
causes of neuroendocrine tumors. All of this will help us to better understand neuroendocrine
cancer, so the investigators can find better ways to treat and diagnose this disease. DNA
will be taken from the blood samples and will be used in future studies. This will be an
important resource from which the investigators can study genes that may be related to a
higher risk of neuroendocrine tumors.
The information collected will include medical information, family history of cancer and your
answers to questions about how the cancer affects quality of life.
Inclusion Criteria:
- Diagnosis of gastroenteropancreatic neuroendocrine tumors or neuroendocrine tumors of
unknown primary
- Willing to donate blood samples
- >= 18years old
- Patients may have received prior hormonal therapy, cytotoxic therapy, irradiation,
immunotherapy or surgical therapy
Exclusion Criteria:
- Have any condition, which in the opinion of the primary MSKCC clinician or
investigators precludes their ability to provide informed consent
We found this trial at
3
sites
650 Commack Rd
Commack, New York 11725
Commack, New York 11725
(631) 623-4000
Phone: 646-888-4185
Memorial Sloan-Kettering Cancer Center at Commack Memorial Sloan Kettering Cancer Center - the world's oldest...
Click here to add this to my saved trials
136 Mountainview Blvd
Basking Ridge, New Jersey 7920
Basking Ridge, New Jersey 7920
(908) 542-3000
Phone: 646-888-4185
Memorial Sloan-Kettering Cancer Center - Basking Ridge At Memorial Sloan Kettering Basking Ridge, we offer...
Click here to add this to my saved trials
1275 York Ave
New York, New York 10021
New York, New York 10021
(212) 639-2000
Principal Investigator: Diane Reidy-Lagunes, MD
Phone: 646-888-4185
Memorial Sloan Kettering Cancer Center Memorial Sloan Kettering Cancer Center — the world's oldest and...
Click here to add this to my saved trials